Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hydrocortisone acetate + lidocaine
- Development stage
- Unknown
- Lead developer
- Reyansh Remedies
- Modality
- Small Molecules
- Administration
- Rectal
01
Overview
Hydrocortisone acetate + lidocaine is a combination pharmaceutical product developed by Reyansh Remedies for rectal administration, typically in the form of a suppository. It combines the anti-inflammatory properties of hydrocortisone acetate, a synthetic corticosteroid that acts as a glucocorticoid receptor agonist, with the local anesthetic effects of lidocaine (also known as lignocaine), which inhibits voltage-gated sodium channels. This dual-action formulation is designed to provide symptomatic relief from pain, itching, and inflammation associated with anorectal conditions such as hemorrhoids, anal fissures, and proctitis. The product is approved and marketed as part of Reyansh Remedies' portfolio of generic medications.
- Brand names
- AnaMantle HCLida Mantle HCLidaMantle HC ReliefLidoCortPeranex HCAna-Lex
- Other names
- hydrocortisone acetate + lignocainelignocaine + hydrocortisone acetate
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on hydrocortisone acetate + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hydrocortisone acetate + lidocaine.